technology
Technology

Email Alerts

Email Address *
Mailing Lists *

 
Enter the code shown above.

Pipeline

Opexa Therapeutics is developing highly differentiated, personalized immunotherapies.

*Option & License agreement signed with Merck Serono, MS indications only, worldwide, excluding Japan